International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia (STARGATE)

November 30, 2023 updated by: University of Turin, Italy

According to WHO, more than 230 million major surgical procedures are carried out under general anaesthesia each year worldwide. Despite important technological advances, airway management remains a major challenge in anaesthesiology. Data from large perspective studies on current incidence of major peri-intubation adverse events are lacking in the anaesthesia setting, especially on outcomes such as peri-intubation cardiovascular collapse, severe hypoxemia, and cardiac arrest. These events are more common in case of difficulties with airway management so that first pass intubation failure significantly increase the risks. Moreover, it has been documented that even transient hypotension during general anaesthesia, may have long-term consequences and may be associated with a worse outcome in patients undergoing non-cardiac surgery. The primary aim of the study is to assess the current incidence of major peri-intubation adverse events during anaesthesia in patients undergoing elective or emergency surgery and in the setting of nonoperating room anesthesia. The secondary aim is to assess the current practice of airway management during anesthesia worldwide.

STARGATE Study will be a large international observational study recruiting all consecutive adult (≥ 18 years old) patients undergoing general anesthesia in operating room and outside operating room. Primary outcome will be a composite of cardiovascular collapse, cardiac arrest and severe hypoxemia.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

According to WHO, more than 230 million major surgical procedures are carried out under general anaesthesia each year worldwide. Despite important technological advances, airway management remains a major challenge in anesthesiology. Data from large perspective studies on current incidence of major peri-intubation adverse events are lacking in the anesthesia setting, especially on outcomes such as peri-intubation cardiovascular collapse, severe hypoxemia, and cardiac arrest. These events are more common in case of difficulties with airway management so that first pass intubation failure significantly increase the risks. Moreover, it has been documented that even transient hypotension during general anesthesia, may have long-term consequences and may be associated with a worse outcome in patients undergoing non-cardiac surgery. The primary aim of the study is to assess the current incidence of major peri-intubation adverse events during anesthesia in patients undergoing elective or emergency surgery and in the setting of non-operating room anesthesia. The secondary aim is to assess the current practice of airway management during anesthesia worldwide.

Study design: International, multicenter, prospective cohort study

Inclusion criteria: We will include all adult (≥ 18 years old) patients undergoing intubation for general anaesthesia in operating room (OR) or non-operating room anaesthesia (NORA).

Exclusion criteria: Airway management during cardiopulmonary resuscitation; critically ill patients undergoing intubation due to their underlying clinical condition.

Primary outcome: At least one of the following major peri-intubation adverse events occurring within 30 minutes from intubation or up to surgical incision: severe hypoxia, cardiovascular collapse, cardiac arrest.

Study duration: All centers will enroll all consecutive patients meeting study criteria up to 50 maximum patients for each center.

Collected data: We will collect the following information:

  • Informed consent and admission data
  • Demographic and clinical characteristics
  • Type of procedure (time, setting, type of surgery, elective or emergency
  • Airway evaluation (anticipated difficult airway management)
  • Monitoring applied during the procedure
  • Patient's parameters
  • Preoxygenation method and use of apnoeic oxygenation (position during preoxygenation, rapid sequence induction applied)
  • Drugs used for induction (molecules and doses)
  • Elective method for laryngoscopy
  • Operator's characteristics
  • Method used for the second (and following) attempt
  • Method used for adequate tube placement confirmation
  • Duration of laryngoscopy
  • Outcome of endotracheal intubation (total number of attempts, laryngoscopy view, minimum SpO2 during laryngoscopy, need for LMA)
  • Intubation-related complications (severe cardiovascular collapse, severe and mild hypoxemia, cardiac arrest, airway injury or any bleeding, aspiration of gastric contents, dental injury, emergency front of neck airway (FONA), cannot intubate cannot oxygenate scenario (CICO), unplanned need for ICU secondary to airway management complications)
  • Extubation procedure.

Study Type

Observational

Enrollment (Estimated)

10500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Paris, France
        • Cochin University Hospital, Assistance Publique - Hôpitaux de Paris
      • Mumbai, India
        • Tata Memorial Hospital
        • Contact:
          • Sheila Myatra
      • Galway, Ireland
        • University Hospital of Galway
        • Contact:
          • John G Laffey
      • Milan, Italy
        • ASST Grande Ospedale Metropolitano Niguarda
        • Contact:
          • Vito Torrano
      • Trento, Italy
        • Ospedale Santa Chiara, APSS Trento
        • Contact:
          • Giacomo Bellani
        • Contact:
          • Silvia De Rosa
    • Monza E Brianza
      • Monza, Monza E Brianza, Italy
        • Fondazione IRCCS San Gerardo dei Tintori
        • Contact:
          • Emanuele Rezoagli
    • TO
      • Orbassano, TO, Italy
        • Azienda Ospedaliera Universitaria San Luigi Gonzaga
        • Contact:
      • Torino, TO, Italy
        • A.O.U. Città della Salute e della Scienza
        • Contact:
          • Francesca Collino
    • Texas
      • Dallas, Texas, United States, 75390
        • University of Texas Southwestern Medical Center
        • Contact:
          • Kunal Karamchandani
      • Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult, not critically ill patients, undergoing intubation to receive surgery or any kind of diagnostic or therapeutic procedure under general anesthesia

Description

Inclusion Criteria:

  • All adult (≥ 18 years old) patients undergoing intubation for general anaesthesia in operating room (OR) or non-operating room anaesthesia (NORA).

Exclusion Criteria:

  • Airway management during cardiopulmonary resuscitation.
  • Critically ill patients undergoing intubation due to their underlying clinical condition

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients undergoing anesthesia in operating room and outside operating room
Patients undergoing elective or emergency tracheal intubation to receive general anesthesia for surgery in operating room or outside operating room (e.g. endoscopy and radiology unit, cardiology lab cath)
Advanced airway management with tracheal intubation performed after induction with hypnotic and/or opioid drugs and laryngoscopy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Major peri-intubation adverse event
Time Frame: 30 minutes from induction

Defined as at least one of the following events:

  • Cardiovascular collapse (at least one of the following):

    1. Systolic arterial pressure < 65 mmHg
    2. Systolic arterial pressure < 90 mmHg for > 15 minutes
    3. New need of vasopressors and/or fluid load > 15 ml/kg to maintain the target blood pressure
  • Cardiac arrest
  • Severe hypoxemia (SpO2 < 80%)
30 minutes from induction

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Minor peri-intubation adverse events
Time Frame: 30 minutes from induction

At least one of the following:

  • Moderate hypoxia (SpO2 < 93%)
  • Airway injury
  • Clinically relevant bleeding
  • Oral aspiration of gastric contents
  • Dental injury
30 minutes from induction
Difficult facemask ventilation
Time Frame: 30 minutes from induction
Impossibility to provide adequate ventilation because of one or more of the following problems: inadequate mask seal, excessive gas leak, or excessive resistance to the ingress or egress of gas
30 minutes from induction
First pass success rate
Time Frame: 30 minutes from induction
Incidence of successful intubation after a single attempt of laryngoscopy
30 minutes from induction

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Emergency front of neck access (eFONA)
Time Frame: 30 minutes from induction
Emergency need for invasive access to the patient's neck to provide adequate oxygenation (e.g. cricothyroidotomy, percutaneous tracheostomy, surgical tracheostomy).
30 minutes from induction
Cannot intubate cannot oxygenate (CICO)
Time Frame: 30 minutes from induction
Impossibility to achieve a successful tracheal intubation and adequate patient's oxygenation
30 minutes from induction
Unplanned need for ICU secondary to airway management complications
Time Frame: 24 hours from induction
Unplanned admission to ICU after an airway-related complication or prolonged/difficult instrumentation
24 hours from induction
In-hospital mortality
Time Frame: 28 days from induction
Death during the same hospital admission
28 days from induction

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Vincenzo Russotto, MD, University of Turin, Italy
  • Principal Investigator: Francesca Collino, MD, University of Turin, Italy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2023

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

February 24, 2023

First Submitted That Met QC Criteria

February 24, 2023

First Posted (Actual)

March 8, 2023

Study Record Updates

Last Update Posted (Actual)

December 1, 2023

Last Update Submitted That Met QC Criteria

November 30, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • STARGATE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Airway Complication of Anesthesia

Clinical Trials on Tracheal intubation

3
Subscribe